Study results prove tirzepatide blunts these flare-ups, giving people steadier weeks and fewer surprises: 38% reduction in the risk of worsening heart failure or cardiovascular death Only 9.9% of tirzepatide users had a major heart failure event, compared to 15.3% on placebo 2
Both sides are planning for a Science Day scheduled by Judge Marston for June 2
Researchers developed IGF-1 LR3 to help them study insulin growth factor 1s actions for extended periods, as IGF-1 has a short lifespan
PlexusDx's Precision Peptide Genetic Test maps 14 metabolic pathways across 49 peptides and 150+ genetic insights, helping identify whether your plateau reflects true dose adequacy or unaddressed genetic predisposition to resistant weight loss
The results of observational studies indicate that low HDL cholesterol concentration is a risk factor for ischaemic heart disease
Some clinicians are prescribing tirzepatide to breastfeeding mothers based on its molecular similarity to GLP-1, its large molecular weight (which reduces breast milk transfer), and the favorable animal data